End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.095 CAD | -5.00% | +5.56% | -5.00% |
Mar. 01 | Willow Biosciences Announces Second Strategic Investment From Kalsec | MT |
Feb. 21 | Willow Biosciences Secures Strategic Investment From Kalsec to Develop Natural Food Ingredient | MT |
Sales 2021 | 0.13 0.18 | Sales 2022 | 0.82 1.11 | Capitalization | 14.23M 19.27M |
---|---|---|---|---|---|
Net income 2021 | -6M -8.13M | Net income 2022 | -14M -18.96M | EV / Sales 2021 | 192,476,654 x |
Net cash position 2021 | 30M 40.63M | Net cash position 2022 | 15.01M 20.32M | EV / Sales 2022 | -947,916 x |
P/E ratio 2021 |
-8.79
x | P/E ratio 2022 |
-0.96
x | Employees | 32 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 72.66% |
1 day | -5.00% | ||
1 week | +5.56% | ||
Current month | -17.39% | ||
1 month | -20.83% | ||
3 months | -5.00% | ||
6 months | +11.76% | ||
Current year | -5.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Savile
CEO | Chief Executive Officer | - | 19-04-11 |
Travis Doupe
DFI | Director of Finance/CFO | - | 19-04-11 |
Trish Choudhary
CTO | Chief Tech/Sci/R&D Officer | - | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Lalonde
CHM | Chairman | 63 | 23-02-20 |
Donald Archibald
BRD | Director/Board Member | 63 | 19-04-11 |
Director/Board Member | 51 | 19-04-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 0.095 | -5.00% | 9,500 |
24-03-26 | 0.1 | +5.26% | 4,000 |
24-03-25 | 0.095 | +5.56% | 226,608 |
24-03-22 | 0.09 | 0.00% | 171,000 |
24-03-21 | 0.09 | 0.00% | 22,001 |
End-of-day quote Toronto S.E., March 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-5.00% | 8.87M | |
+0.44% | 90.27B | |
+9.61% | 44.05B | |
-16.57% | 31.45B | |
+44.99% | 23.35B | |
-9.53% | 16.72B | |
-25.92% | 15.09B | |
-9.55% | 12.82B | |
-7.57% | 11.95B | |
+0.07% | 8.71B |